P

Inventor

SEWARD EILEEN MARY

GB30 patents
⚠️ This page may combine multiple inventors who share the name “SEWARD EILEEN MARY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK SHARP & DOHME

18 patents
US6172077B1Jan 9, 2001

Spiro-azacyclic derivatives and their use as therapeutic agents

MERCK SHARP & DOHME149 citations97
US6114315ASep 5, 2000

Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety

MERCK SHARP & DOHME26 citations92
US5952315ASep 14, 1999

Use of NK-1 receptor antagonists for treating bipolar disorders

MERCK SHARP & DOHME34 citations92
US5728695AMar 17, 1998

Spiroketal derivatives, compositions containing them and their use as therapeutic agents

MERCK SHARP & DOHME26 citations92
US6046195AApr 4, 2000

Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists

MERCK SHARP & DOHME26 citations90
US7638629B2Dec 29, 2009

Piperidines and related compounds for treatment of alzheimer's disease

MERCK SHARP & DOHME13 citations83
US6271230B1Aug 7, 2001

Use of NK-1 receptor antagonists for treating cognitive disorders

MERCK SHARP & DOHME6 citations74
US6071927AJun 6, 2000

Spiro-piperidine derivatives and their use as therapeutic agents

MERCK SHARP & DOHME13 citations74
US5925627AJul 20, 1999

Use of NK-1 receptor antagonists for treating movement disorders

MERCK SHARP & DOHME7 citations74
US6489343B2Dec 3, 2002

Tetrahydropyran derivatives and their use as therapeutic agents

MERCK SHARP & DOHME9 citations73
US6087348AJul 11, 2000

Use of NK-1 receptor antagonists for treating stress disorders

MERCK SHARP & DOHME3 citations63
US5919781AJul 6, 1999

Use of NK-1 receptor antogonists for treating substance use disorders

MERCK SHARP & DOHME5 citations63
US5665883ASep 9, 1997

Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists

MERCK SHARP & DOHME6 citations63
US6458830B1Oct 1, 2002

Tetrahydropyran derivatives and their use as therapeutic agents

MERCK SHARP & DOHME7 citations62
US5747491AMay 5, 1998

Morpholine derivatives and their use as antagonists of tachikinins

MERCK SHARP & DOHME3 citations61
US7101892B2Sep 5, 2006

Sulfone derivatives as 5-HT7 receptor ligands

MERCK SHARP & DOHME2 citations60
US5877316AMar 2, 1999

Morpholine derivatives, compositions containing them and their use as therapeutic agents

MERCK SHARP & DOHME6 citations60
US6096729AAug 1, 2000

Use of NK-1 receptor antagonists for treating amnestic disorders

MERCK SHARP & DOHME0 citations52

VANDRIA SA

4 patents

CASTANEDO GEORGETTE

3 patents

GENENTECH INC

3 patents

MERCK SHARP

1 patent

HEALD ROBERT

1 patent